Spots Global Cancer Trial Database for Feasibility Study to Estimate Number of Patients With Precancerous Areas in Their Airways and the Response to Gefitinib

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Feasibility Study to Estimate Number of Patients With Precancerous Areas in Their Airways and the Response to Gefitinib

Official Title: Tyrosine Kinase Inhibitors in DyplAsia of Lung Epithelium

Study ID: NCT01405846

Conditions

Lung Cancer

Head and Neck Cancer

Interventions

Gefitinib

Study Description

Brief Summary: We are going to use a special type of bronchoscopy test to examine patients who have had previous surgical treatment for lung cancer or head and neck cancer. The aim is to determine a) whether we can identify precancerous changes in their airways b) whether this type of testing is acceptable and c) get an initial idea of whether a new drug called gefitinib has any effect on precancerous areas in the airway.

Detailed Description: